Literature DB >> 21108020

Update: Why diabetes does not resolve in some patients after bariatric surgery.

Mervyn Deitel1.   

Abstract

Bariatric surgery provides resolution of co-morbidities of morbid obesity-importantly diabetes type 2. This is initiated by immediate postoperative decrease in intake or assimilation of glucose and is continued by the substantial loss of adipose tissue. Greater weight loss and greater resolution of type 2 diabetes occur after operations that provide rapid passage of nutrients to the hindgut, which likely results in beta-cell stimulation by incretins. Failure of resolution of the diabetes can result from lack of patient compliance, inadequate weight loss, longstanding uncontrolled diabetes, or when the diabetes is actually a type 1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21108020     DOI: 10.1007/s11695-010-0329-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009.

Authors:  Michel Gagner; Mervyn Deitel; Traci L Kalberer; Ann L Erickson; Ross D Crosby
Journal:  Surg Obes Relat Dis       Date:  2009-06-13       Impact factor: 4.734

2.  Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus.

Authors:  Shashank Shah; Poonam Shah; Jayashree Todkar; Michel Gagner; S Sonar; S Solav
Journal:  Surg Obes Relat Dis       Date:  2009-12-22       Impact factor: 4.734

3.  Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.

Authors:  Tom C Hall; Mike G C Pellen; Peter C Sedman; Prashant K Jain
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

4.  Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.

Authors:  Numan Hamza; Muhammad Hasan Abbas; Ammar Darwish; Zainab Shafeek; John New; Basil J Ammori
Journal:  Surg Obes Relat Dis       Date:  2010-04-07       Impact factor: 4.734

5.  Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes.

Authors:  P Zimmet; R Turner; D McCarty; M Rowley; I Mackay
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

6.  Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition.

Authors:  I Sanderson; M Deitel
Journal:  Ann Surg       Date:  1974-04       Impact factor: 12.969

7.  Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization.

Authors:  Pedro Weslley S Rosário; Janice Sepulveda Reis; Tiago Alvarenga Fagundes; Maria Regina Calsolari; Ricardo Amim; Saulo Cavalcanti Silva; Saulo Purisch
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-02

8.  Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study.

Authors:  Satoshi Murao; Shiori Kondo; Jun Ohashi; Yasuhisa Fujii; Ikki Shimizu; Masao Fujiyama; Keizo Ohno; Yasuharu Takada; Kazuaki Nakai; Yukio Yamane; Haruhiko Osawa; Hideichi Makino
Journal:  Diabetes Res Clin Pract       Date:  2008-03-14       Impact factor: 5.602

9.  Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity.

Authors:  E Näslund; L Backman; J J Holst; E Theodorsson; P M Hellström
Journal:  Obes Surg       Date:  1998-06       Impact factor: 4.129

10.  Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation.

Authors:  R Burstein; Y Epstein; I Charuzi; A Suessholz; E Karnieli; Y Shapiro
Journal:  Int J Obes Relat Metab Disord       Date:  1995-08
View more
  17 in total

1.  A comment on the International Diabetic Federation statement.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

2.  Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Luca Busetto; John Dixon; Maurizio De Luca; Scott Shikora; Walter Pories; Luigi Angrisani
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

3.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 4.  Physiology of weight loss surgery.

Authors:  Chan W Park; Alfonso Torquati
Journal:  Surg Clin North Am       Date:  2011-12       Impact factor: 2.741

5.  The Impact of Laparoscopic Adjustable Gastric Banding on an NHS Cohort of Type 2 Diabetics: a Prospective Cohort Study.

Authors:  Richard J Egan; Andrew B Johnson; Justin D T Morgan; Sally A Norton
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

6.  The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats.

Authors:  Lorea Zubiaga; Rafael Abad; Jaime Ruiz-Tovar; Pablo Enriquez; Juan Antonio Vílchez; Mireia Calzada; José Antonio Pérez De Gracia; Mervyn Deitel
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

Review 7.  The Role of Bariatric Surgery on Diabetes and Diabetic Care Compliance.

Authors:  Hope T Jackson; Chika Anekwe; Julietta Chang; Ivy N Haskins; Fatima Cody Stanford
Journal:  Curr Diab Rep       Date:  2019-11-14       Impact factor: 4.810

8.  Predictors for remission of major components of the metabolic syndrome after biliopancreatic diversion with duodenal switch (BPDDS).

Authors:  Villy Våge; Roy M Nilsen; Arnold Berstad; Jan Behme; Nils Sletteskog; Ronny Gåsdal; Camilla Laukeland; Gunnar Mellgren
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

9.  Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study.

Authors:  Christopher D Still; G Craig Wood; Peter Benotti; Anthony T Petrick; Jon Gabrielsen; William E Strodel; Anna Ibele; Jamie Seiler; Brian A Irving; Melisa P Celaya; Robin Blackstone; Glenn S Gerhard; George Argyropoulos
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01       Impact factor: 32.069

10.  Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.

Authors:  Chih Kun Huang; Chi-Ming Tai; Po-Chih Chang; Kirubakaran Malapan; Ching-Chung Tsai; Kamthorn Yolsuriyanwong
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.